CATX – Perspective Therapeutics Inc
Investors holding1
Combined shares33,714
Combined reported value$93K
CATX chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.
Ownership
| Investor | % of their portfolio | Change | Shares | Reported value | Period |
|---|---|---|---|---|---|
| Paul Tudor Jones narrow view | 0.00 | Added 86.2% | 33,714 | $93K | Q3 2026 |
Activity: last 4 quarters
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Paul Tudor Jones narrow view | Added 86.2% | 33,714 | 0.00 |
| Q2 2026 | Paul Tudor Jones narrow view | Reduced 46.7% | 18,106 | 0.00 |
| Q1 2026 | Paul Tudor Jones narrow view | New | 33,946 | 0.00 |
Added: opened or increased
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Paul Tudor Jones narrow view | Added 86.2% | 33,714 | 0.00 |
| Q1 2026 | Paul Tudor Jones narrow view | New | 33,946 | 0.00 |
Reduced: reduced or closed
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q2 2026 | Paul Tudor Jones narrow view | Reduced 46.7% | 18,106 | 0.00 |
History
1 peakQ3 2026: 1 tracked investors
20242026
Shares held, last 8 quarters
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Paul Tudor Jones | 33.7K | 18.1K | 33.9K | – | – | – | – | 28.6K |
– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).